EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Determining Prognostic Factors of Disease-Free Survival in Breast Cancer Using Censored Quantile Regression

Akram Yazdani iD, Shahpar Haghighat iD

Breast Cancer: Basic and Clinical Research · 2022-01 · 16

DOI: 10.1177/11782234221108058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer: Basic and Clinical Research, online erschienen am 29.06.2022. Verfasst von Akram Yazdani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics and Epidemiology, School of Public Health, Kashan University of Medical Sciences, Kashan, Iran. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The analysis of disease-free survival and related factors leads to a better understanding of the patient’s condition and recurrence-related characteristics and provides a basis for more appropriate treatment guidance. In this study, we aimed to investigate the role of prognostic factors on disease-free survival in breast cancer with a quantile regression model.

Methods

This retrospective study was conducted by reviewing data obtained from 2056 breast cancer patients. Age at diagnosis and education status, tumor size, lymph node ratio, tumor grade, estrogen receptor and progesterone receptor, type of surgery, use of radiotherapy, chemotherapy, and hormone therapy were the prognosis factors considered in this study. A quantile regression model was used to investigate prognostic factors of disease-free survival in breast cancer.

Results

Disease recurrence was verified in 251 (13.9%) women, and 39 (0.02%) women died before experience recurrence. The 10th percentile of disease-free survival for patients with the hormone therapy was 23.85 months greater than patients who did not receive this treatment ( P value < .001). In the examination of the tumor size, the 10th and 20th percentiles of disease-free survival for patients with tumor size > 5 cm were 31.06 and 27 months less than patients with the tumor size < 2 cm, respectively ( P value = .006 and .021, respectively). Compared with grade 1 tumors, the 10th and 20th percentiles of disease-free survival for patients with grade 3 tumors decreased 30.11 and 38.32 months, respectively ( P value < .001 and .038, respectively). The 10th and 20th percentiles of disease-free survival decreased 28.16 and 45.32 months with a 1 unit increase in lymph node ratio, respectively ( P value = .032 and .032, respectively).

Conclusions

Among the prognostic factors, tumor size, grade, and lymph node ratio showed a close relationship with disease-free survival in breast cancer. The findings indicated that developing public screening and educational programs through the health care system with more emphasis on low-educated women is needed among Iranian women.

Schlagwörter

Stichwörter der Autor:innen

Breast cancerLaplace regressiondisease-free survivalquantile regression

Autor:innen und Institutionen

  • Department of Biostatistics and Epidemiology, School of Public Health, Kashan University of Medical Sciences, Kashan, Iran.
  • Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.

ORCID-Profile: Akram Yazdani, Shahpar Haghighat

Zitieren

APA

Yazdani, A., & Haghighat, S. (2022). Determining Prognostic Factors of Disease-Free Survival in Breast Cancer Using Censored Quantile Regression. Breast Cancer: Basic and Clinical Research, 16. https://doi.org/10.1177/11782234221108058

Vancouver

Yazdani A, Haghighat S. Determining Prognostic Factors of Disease-Free Survival in Breast Cancer Using Censored Quantile Regression. Breast Cancer: Basic and Clinical Research. 2022;16. doi:10.1177/11782234221108058

BibTeX
@article{Yazdani2022,
  author = {Yazdani, Akram and Haghighat, Shahpar},
  title = {Determining Prognostic Factors of Disease-Free Survival in Breast Cancer Using Censored Quantile Regression},
  journal = {Breast Cancer: Basic and Clinical Research},
  year = {2022},
  volume = {16},
  doi = {10.1177/11782234221108058}
}
Kostenlos starten →